glycerol has been researched along with fenofibrate in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hu, L; Jia, Y; Niu, F; Wu, H; Yan, C; Yang, X | 1 |
| Bhakay, A; Bilgili, E; Davé, RN; Iqbal, Z; Jerez-Rozo, JI; Michniak-Kohn, B; Pandya, N; Romañach, RJ; Sievens-Figueroa, L | 1 |
| Serajuddin, AT; Shah, AV | 1 |
| Adedapo, AA; Oyekan, AO | 1 |
| Hattori, H; Ishizawa, K; Kono, M; Matsushita, T; Miyamoto, L; Nemoto, H; Tsuchiya, K; Watanabe, M | 1 |
| Abe, S; Hattori, H; Ishizawa, K; Kamiya, M; Kono, M; Matsushita, T; Miyamoto, L; Nemoto, H; Taoka, C; Tomida, Y; Tsuchiya, K; Watanabe, M | 1 |
| Kanaujia, P; Ng, WK; Tan, RB | 1 |
| Cui, F; Gan, Y; Mu, H; Xia, D; Yang, M | 1 |
| Afolabi, A; Bilgili, E; Davé, RN; Iqbal, Z; Krull, SM; Li, M; Susarla, R; Ying, Y | 1 |
| Abed, M; Davé, RN; Li, Y; Zhang, L | 1 |
| Aloia, M; Davé, RN; Kunnath, K; Lin, H; Pielecha-Safira, B; Rajai, PM; Zhang, L | 1 |
12 other study(ies) available for glycerol and fenofibrate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Design of fenofibrate microemulsion for improved bioavailability.
Topics: Administration, Oral; Animals; Biological Availability; Capsules; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dogs; Drug Compounding; Drug Stability; Emulsions; Ethylene Glycols; Fenofibrate; Glycerides; Glycerol; Hypolipidemic Agents; Male; Microscopy, Electron, Transmission; Polyethylene Glycols; Solubility; Surface-Active Agents | 2011 |
Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
Topics: Chemistry, Pharmaceutical; Crystallization; Crystallography, X-Ray; Drug Carriers; Drug Compounding; Elastic Modulus; Feasibility Studies; Fenofibrate; Glycerol; Griseofulvin; Hydrogen Bonding; Hypromellose Derivatives; Kinetics; Methylcellulose; Microscopy, Electron, Scanning; Nanoparticles; Nanotechnology; Naproxen; Particle Size; Plasticizers; Solubility; Spectroscopy, Near-Infrared; Spectrum Analysis, Raman; Surface Properties; Surface-Active Agents; Technology, Pharmaceutical | 2012 |
Development of solid self-emulsifying drug delivery system (SEDDS) I: use of poloxamer 188 as both solidifying and emulsifying agent for lipids.
Topics: Drug Delivery Systems; Emulsifying Agents; Emulsions; Fatty Acids; Fenofibrate; Glycerol; Particle Size; Poloxamer; Polyethylene Glycols; Probucol; Solubility; Water | 2012 |
Effects of fenofibrate, a PPAR-α ligand, on the haemodynamics of glycerol-induced renal failure in rats.
Topics: Animals; Arterial Pressure; Fenofibrate; Glycerol; Hemodynamics; Kidney; Ligands; Male; PPAR alpha; Protective Agents; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renal Insufficiency | 2013 |
Cytotoxicity evaluation of symmetrically branched glycerol trimer in human hepatocellular carcinoma HepG2 cells.
Topics: Carcinoma, Hepatocellular; Cell Survival; Fenofibrate; Glycerol; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Liver Neoplasms; Solubility | 2012 |
A novel prodrug strategy for extremely hydrophobic agents: conjugation to symmetrically branched glycerol trimer improves pharmacological and pharmacokinetic properties of fenofibrate.
Topics: Fenofibrate; Glycerol; Hydrophobic and Hydrophilic Interactions; Prodrugs | 2013 |
Solid self-emulsifying drug delivery system (S-SEDDS) for improved dissolution rate of fenofibrate.
Topics: Drug Delivery Systems; Emulsions; Fenofibrate; Glycerol; Hypolipidemic Agents; Solubility; Triglycerides | 2014 |
Design of lipid matrix particles for fenofibrate: effect of polymorphism of glycerol monostearate on drug incorporation and release.
Topics: Calorimetry, Differential Scanning; Crystallization; Drug Design; Drug Stability; Fenofibrate; Glycerol; Hypolipidemic Agents; Indicators and Reagents; Microscopy, Electron, Transmission; Monoglycerides; Nanoparticles; Particle Size; Solubility; Stearates; X-Ray Diffraction | 2014 |
Polymer strip films as a robust, surfactant-free platform for delivery of BCS Class II drug nanoparticles.
Topics: Azo Compounds; Drug Delivery Systems; Fenofibrate; Glycerol; Griseofulvin; Hypromellose Derivatives; Nanoparticles; Naproxen; Phenylbutazone; Solubility | 2015 |
Incorporation of surface-modified dry micronized poorly water-soluble drug powders into polymer strip films.
Topics: Drug Delivery Systems; Drug Liberation; Fenofibrate; Glycerol; Hypolipidemic Agents; Hypromellose Derivatives; Powders; Silicon Dioxide; Solubility; Surface Properties; Viscosity; Water | 2018 |
Impact of Superdisintegrants and Film Thickness on Disintegration Time of Strip Films Loaded With Poorly Water-Soluble Drug Microparticles.
Topics: Carboxymethylcellulose Sodium; Drug Delivery Systems; Drug Liberation; Excipients; Fenofibrate; Glycerol; Hypolipidemic Agents; Hypromellose Derivatives; Solubility; Starch; Viscosity; Water | 2018 |